论文部分内容阅读
作者对12例肾癌组织标本肿瘤浸润淋巴细胞(TIL)的抗瘤活性进行了研究。结果显示,自12例肾癌标本中10例成功地分离到TIL,经4周培养平均扩增85.92倍,表型分析以T淋巴细胞为主,随培养时间延长T4比率逐渐减少,T8比率逐渐增加,培养后TIL抗瘤活性显著增强但对自体肿瘤细胞特异杀伤问题需进一步研究,初步结果表明TIL治疗肾癌具有可行性。
The authors studied the antitumor activity of tumor infiltrating lymphocytes (TILs) in 12 cases of renal cell carcinoma. The results showed that TIL was successfully isolated from 10 cases of renal cell carcinoma in 12 cases and amplified 85.92 times on average after 4 weeks of culture. The T lymphocytes were the main phenotypes, and the ratio of T4 decreased with the increase of culture time. T8 The ratio increased gradually, the TIL anti-tumor activity was significantly enhanced after culturing, but the specific killing of autologous tumor cells needs further study. The preliminary results show that TIL is feasible for treating renal cell carcinoma.